vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Lionsgate Studios Corp. (LION). Click either name above to swap in a different company.

Lionsgate Studios Corp. is the larger business by last-quarter revenue ($724.3M vs $487.7M, roughly 1.5× CLOVER HEALTH INVESTMENTS, CORP.). Lionsgate Studios Corp. runs the higher net margin — -6.4% vs -10.1%, a 3.7% gap on every dollar of revenue. On growth, Lionsgate Studios Corp. posted the faster year-over-year revenue change (52.5% vs 44.7%). CLOVER HEALTH INVESTMENTS, CORP. produced more free cash flow last quarter ($-69.0M vs $-111.9M).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Lionsgate Canada is a Canadian entertainment company and a subsidiary of Lionsgate Studios. Based in the Entertainment District in the city of Toronto, the company is primarily involved in the acquisition and production of films and television series.

CLOV vs LION — Head-to-Head

Bigger by revenue
LION
LION
1.5× larger
LION
$724.3M
$487.7M
CLOV
Growing faster (revenue YoY)
LION
LION
+7.7% gap
LION
52.5%
44.7%
CLOV
Higher net margin
LION
LION
3.7% more per $
LION
-6.4%
-10.1%
CLOV
More free cash flow
CLOV
CLOV
$42.9M more FCF
CLOV
$-69.0M
$-111.9M
LION

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CLOV
CLOV
LION
LION
Revenue
$487.7M
$724.3M
Net Profit
$-49.3M
$-46.2M
Gross Margin
Operating Margin
-10.1%
5.0%
Net Margin
-10.1%
-6.4%
Revenue YoY
44.7%
52.5%
Net Profit YoY
-123.2%
59.3%
EPS (diluted)
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
LION
LION
Q4 25
$487.7M
$724.3M
Q3 25
$496.6M
$475.1M
Q2 25
$477.6M
$525.9M
Q1 25
$462.3M
Q4 24
$337.0M
Q3 24
$331.0M
Q2 24
$356.3M
Q1 24
$346.9M
Net Profit
CLOV
CLOV
LION
LION
Q4 25
$-49.3M
$-46.2M
Q3 25
$-24.4M
$-113.5M
Q2 25
$-10.6M
$-108.9M
Q1 25
$-1.3M
Q4 24
$-22.1M
Q3 24
$-9.2M
Q2 24
$7.4M
Q1 24
$-19.2M
Gross Margin
CLOV
CLOV
LION
LION
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
LION
LION
Q4 25
-10.1%
5.0%
Q3 25
-4.9%
-9.7%
Q2 25
-2.2%
-2.0%
Q1 25
-0.3%
Q4 24
-6.4%
Q3 24
-2.7%
Q2 24
2.0%
Q1 24
-6.5%
Net Margin
CLOV
CLOV
LION
LION
Q4 25
-10.1%
-6.4%
Q3 25
-4.9%
-23.9%
Q2 25
-2.2%
-20.7%
Q1 25
-0.3%
Q4 24
-6.6%
Q3 24
-2.8%
Q2 24
2.1%
Q1 24
-5.5%
EPS (diluted)
CLOV
CLOV
LION
LION
Q4 25
$-0.16
Q3 25
$-0.39
Q2 25
$-0.40
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
LION
LION
Cash + ST InvestmentsLiquidity on hand
$78.3M
$182.4M
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$308.7M
$-1.3B
Total Assets
$541.0M
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
LION
LION
Q4 25
$78.3M
$182.4M
Q3 25
$202.4M
Q2 25
$186.1M
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Q1 24
$208.3M
Total Debt
CLOV
CLOV
LION
LION
Q4 25
$1.8B
Q3 25
$1.8B
Q2 25
$1.5B
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
LION
LION
Q4 25
$308.7M
$-1.3B
Q3 25
$340.9M
$-1.3B
Q2 25
$344.2M
$-1.1B
Q1 25
$336.1M
Q4 24
$341.1M
Q3 24
$342.2M
Q2 24
$324.9M
Q1 24
$292.5M
Total Assets
CLOV
CLOV
LION
LION
Q4 25
$541.0M
$5.2B
Q3 25
$559.7M
$5.2B
Q2 25
$575.0M
$5.2B
Q1 25
$583.7M
Q4 24
$580.7M
Q3 24
$653.0M
Q2 24
$674.2M
Q1 24
$671.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
LION
LION
Operating Cash FlowLast quarter
$-66.9M
$-108.9M
Free Cash FlowOCF − Capex
$-69.0M
$-111.9M
FCF MarginFCF / Revenue
-14.1%
-15.4%
Capex IntensityCapex / Revenue
0.4%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
LION
LION
Q4 25
$-66.9M
$-108.9M
Q3 25
$12.1M
$-104.0M
Q2 25
$5.4M
$-31.0M
Q1 25
$-16.3M
Q4 24
$34.8M
Q3 24
$50.0M
Q2 24
$44.8M
Q1 24
$25.9M
Free Cash Flow
CLOV
CLOV
LION
LION
Q4 25
$-69.0M
$-111.9M
Q3 25
$11.4M
$-107.2M
Q2 25
$4.8M
$-34.5M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
Q1 24
$25.5M
FCF Margin
CLOV
CLOV
LION
LION
Q4 25
-14.1%
-15.4%
Q3 25
2.3%
-22.6%
Q2 25
1.0%
-6.6%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Q1 24
7.3%
Capex Intensity
CLOV
CLOV
LION
LION
Q4 25
0.4%
0.4%
Q3 25
0.1%
0.7%
Q2 25
0.1%
0.7%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
CLOV
CLOV
LION
LION
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

LION
LION

Television Production$303.1M42%
Digital Media$155.1M21%
Third Party Purchasers Individual Agreements$91.2M13%
Theatrical$70.7M10%
Domestic Television$43.1M6%
Starz Business$24.1M3%
Other Media$17.6M2%
Packaged Media$14.1M2%

Related Comparisons